Open AccessPilot Safety Trial of Deferiprone in 10 Subjects With Superficial Siderosis
Author(s) -
Michael Levy,
R. Llinás
Publication year - 2011
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.111.628032
Subject(s) - deferiprone , medicine , siderosis , superficial siderosis , hemosiderin , adverse effect , deferasirox , population , thalassemia , pathology , disease , dementia , cerebral amyloid angiopathy , environmental health
Superficial siderosis is a neurodegenerative disease caused by toxic accumulation of hemosiderin on the surface of the brain and spinal cord for which there is no known effective treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom